Advanced Accelerator Application SA (NASDAQ:AAAP) has inked a NETSPOT distribution deal with Cardinal Health Inc (NYSE:CAH), bringing to two the number of partners tapped to supply the patented ...
SAINT-GENIS-POUILLY, France, May 18, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM) ...
The Food and Drug Administration (FDA) has approved Netspot (Advanced Accelerator Applications), a radioactive diagnostic agent for positron emission topography (PET) imaging. The probe will aid in ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the diagnostic imaging agent Netspot to detect rare neuroendocrine tumors. Netspot (Advanced ...
After earning priority review status, the French-based pharmaceutical company Advanced Accelerator Applications just received FDA approval for a new agent to image neuroendocrine tumors (NET).
Insurance Australia Group posted higher annual cash earnings on Wednesday, beating estimates, as increased premiums and lower-than-expected natural peril costs improved performance and allowed the top ...
The FDA has approved a novel PET imaging diagnostic agent for neuroendocrine tumors from Advanced Accelerator Applications ($AAAP). The nod comes 7 months after the ...
$3.9 Billion All Cash Proposed Tender Offer by Novartis European Approval of Lutetium Lu 177 Dotatate* (Lutathera ®) for GEP-NETs Recent Highlights: SAINT-GENIS-POUILLY, France, Nov. 17, 2017 (GLOBE ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA approved Netspot, the first kit ...
* Advanced Accelerator Applications Announces FDA Approval Of Netspot(Tm) (Somakit-tate), a kit for the preparation of Gallium GA 68 Dotatate for neuroendocrine tumor detection Sign up here. * ...
Last month, word on the street was that Novartis was in talks to buy Advanced Accelerator Applications, a French company that makes radiotherapies for cancer patients. Turns out, that scuttlebutt was ...